MMP2 and prostate cancer: In line with these data, we found a significant increase of MMP-2 and MMP-9 gelatinase activity in a transgenic murine model of prostate cancer knock-out for CLU (TRAMP/CLUKO) compared with age-matched prostate cancer-prone mice (TRAMP) expressing CLU [162].